Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
LiguaTSE:7090 +2.94%55 EBITDA Margin % is 14.03% as of Mar. 2026, which is 59% above its 10-year median of 8.81. GuruFocus rates TSE:7090 with a GF Score™ of 55/100 and a GF Value™ of 円892.32 (Fairly Valued). The stock has 3 warning signs investors should review. Among 670 Healthcare Providers & Services companies, Ligua ranks worse than 75.22% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Ligua's EBITDA for the
three
months ended in Mar. 2026 was 円95 Mil. Ligua's Revenue for the
three
months ended in Mar. 2026 was 円678 Mil. Therefore, Ligua's EBITDA margin for the quarter that ended in Mar. 2026 was 14.03%.
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Ligua EBITDA Margin % Related Terms
Ligua EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Ligua's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:7090 vs HCA, THC, DVA: EBITDA Margin % Comparison
For the Medical Care Facilities subindustry, Ligua's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ligua EBITDA Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Ligua's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Ligua's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ligua (TSE:7090) has a EBITDA Margin % of 14.03% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Ligua and its competitors. This is 59% above median its historical median of 8.81. According to the industry distribution chart, Ligua ranks #504 out of 670 companies in the Healthcare Providers & Services industry, placing it in the top 75.2%.
Is Ligua's EBITDA Margin % too high?
Ligua's current EBITDA Margin % of 14.03% is 59% above median its 10-year median of 8.81. The Healthcare Providers & Services industry median EBITDA Margin % is 10.24. Ligua's value of 14.03% is 37.1% above this industry median. Based on the distribution chart, Ligua ranks #504 out of 670 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Ligua has a GF Score™ of 55/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Ligua's EBITDA Margin % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Ligua ranks #504 out of 670 companies for EBITDA Margin %. This places Ligua in the lower half of its industry. The industry median EBITDA Margin % is 10.24. Ligua's value of 14.03% is 37.1% above this benchmark. While the company's 10-year median is 8.81 vs. the industry median of 10.24, Ligua has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Healthcare Providers & Services company?
The median EBITDA Margin % among Healthcare Providers & Services companies is 10.24, based on 670 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ligua's current EBITDA Margin % of 14.03% is 37.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Ligua and its competitors. For the Healthcare Providers & Services industry, the median EBITDA Margin % is 10.24 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ligua's current EBITDA Margin % is 14.03%, which is 59% above median its own 10-year median of 8.81. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ligua stock overvalued right now?
Based on GuruFocus' analysis, Ligua (TSE:7090) is currently considered Fairly Valued. The stock's GF Value™ is 円892.32, compared to a current price of 円946.00 — trading 6% above its estimated fair value. The current EBITDA Margin % is 14.03%, which is 59% above median its 10-year median of 8.81 and 37.1% above the Healthcare Providers & Services industry median of 10.24. Ligua's overall GF Score™ is 55/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Ligua (TSE:7090), the current EBITDA Margin % is 14.03% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ligua (TSE:7090) Overvalued in 2026?
Based on GuruFocus' analysis, Ligua stock appears to be overvalued.
The current stock price of 円946.00 is trading 6% above its estimated GF Value™ of 円892.32.
GuruFocus considers Ligua to be Fairly Valued.
Key valuation signals for TSE:7090:
EBITDA Margin %: 14.03% (59% above median its 10-year median of 8.81)
GF Value™: 円892.32 vs. price of 円946.00 (6% above fair value)
Industry Position: 37.1% above the Healthcare Providers & Services median (#504 of 670)
No single metric tells the full story. See the TSE:7090 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ligua Inc is a consulting company providing management support to the healthcare industry for osteopaths. The company's services include sales office operations such as sales improvement, organizational management, executive education, and recruitment, to corporate management areas such as management of management figures and creation of business plans.
55GF Score
Get the complete analysis for TSE:7090
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:7090 has been successfully added to your 
